Rankings
▼
Calendar
INSM FY 2023 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena
INSM
Insmed Incorporated
$31B
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$305M
+24.4% YoY
Gross Profit
$240M
78.5% margin
Operating Income
-$710M
-232.5% margin
Net Income
-$750M
-245.6% margin
EPS (Diluted)
$-5.34
Cash Flow
Operating Cash Flow
-$536M
Free Cash Flow
-$550M
Stock-Based Comp.
$75M
Balance Sheet
Total Assets
$1.3B
Total Liabilities
$1.7B
Stockholders' Equity
-$332M
Cash & Equivalents
$482M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$305M
$245M
+24.4%
Gross Profit
$240M
$190M
+26.0%
Operating Income
-$710M
-$457M
-55.2%
Net Income
-$750M
-$482M
-55.7%
← Q4 2022
All Quarters
Q1 2023 →